Latest California Healthline Stories
Lifting DC’s Strict Indoor Mask Mandate Triggers Mix of Confusion, Anxiety and Relief
Some business owners, wondering whether it’s too soon to ease the requirement, long for more guidance and support from the mayor.
Why You Can’t Find Cheap At-Home Covid Tests
You probably won’t be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.
‘An Arm and a Leg’: The Insurance Warrior’s Battle Plan
Health care — and how much it costs — is scary. But knowledge is power. Take a master class in winning insurance appeals. In the case of Matthew Lientz, taking on his insurance also meant going up against his employer.
Etching the Pain of Covid Into the Flesh of Survivors
Memorial tattoos have grown more popular in recent years. Since parlors reopened after the lockdown, inkers have found that many people are eager to memorialize relatives and friends lost to covid.
What Happens After a Campus Suicide Is a Form of Prevention, Too
The scientific term is “postvention,” and it informs how to navigate the emotional challenges that follow such a tragedy.
Vaccine-or-Test Requirements Increase Work and Costs for Governments
But state and local officials embrace the requirement because it creates a safer workplace while allowing employees to continue working.
A Covid Head-Scratcher: Why Lice Lurk Despite Physical Distancing
With kids back in school, business is picking back up for professional nitpickers. But how are kids getting head lice if they’re physically distancing in the classroom?
The ER Charged Him $6,500 for Six Stitches. No Wonder His Critically Ill Wife Avoided the ER.
With few options for health care in their rural community, a Tennessee couple’s experience with one outrageous bill could have led to a deadly decision the next time they needed help.
KHN’s ‘What the Health?’: Boosting Confusion
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.
Schools, Pediatricians Look to Make Up Lost Ground on Non-Covid Vaccinations
Health officials hope the rollout of covid shots for young children and other initiatives will boost routine vaccine rates that dropped during the pandemic and narrow socioeconomic disparities.